Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
MSD, known as Merck & Co., Inc. in the United States and Canada, is a premier, research-intensive biopharmaceutical company. For more than 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases.
Serves as the primary center for global strategy, research and development leadership, and corporate administration for MSD's worldwide operations.
The Rahway site has a long history with the company and has undergone significant modernization. It is a key R&D and manufacturing hub, featuring state-of-the-art laboratories and production facilities.
The headquarters fosters a collaborative and innovative environment, focused on scientific excellence and patient-centric solutions. Employees engage in cutting-edge research and global health initiatives.
The Rahway headquarters symbolizes MSD's enduring commitment to scientific discovery and its role as a major hub for pharmaceutical innovation, impacting global health.
MSD operates in over 140 countries worldwide, supporting a broad range of functions globally including research and development, manufacturing and supply, commercial operations, and medical affairs. This extensive network enables MSD to discover, develop, and deliver innovative health solutions to patients and populations across the globe, addressing diverse medical needs and health system challenges.
126 East Lincoln Avenue
Rahway
New Jersey
USA
Address: MSD Merck Sharp & Dohme AG, Werftestrasse 4, 6005 Lucerne, Switzerland
Coordinates activities across multiple European countries, ensuring alignment with global strategy and addressing specific healthcare needs of the European market.
Address: MSD Pharma (Singapore) Pte. Ltd., 152 Beach Road, #23-00 Gateway East, Singapore 189721
Drives growth and healthcare impact in the Asia Pacific region, adapting global strategies to local market conditions and fostering partnerships to improve patient outcomes.
Address: MSD UK, 120 Moorgate, London, EC2M 6UR, United Kingdom
Ensures delivery of MSD's medicines and vaccines to UK patients, engages with the NHS and regulatory bodies, and contributes to the UK's life sciences ecosystem.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, MSD' leadership includes:
MSD has been backed by several prominent investors over the years, including:
MSD has experienced several key leadership appointments and transitions over the past 12-18 months aimed at bolstering its strategic priorities across research, commercial operations, and corporate functions. These changes reflect the company's dynamic approach to leadership in an evolving global healthcare landscape.
Discover the tools MSD uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
MSD, like many large multinational corporations, primarily uses a standardized email format for its employees, typically combining the employee's first and last names. For communications related to the US and Canada, @merck.com is used, while @msd.com is common for international communications.
firstname.lastname@msd.com (or firstname.lastname@merck.com for US/Canada)
Format
jane.doe@msd.com
Example
85%
Success rate
Merck.com News Release • May 7, 2024
MSD reported positive topline results from two Phase 3 trials (STRIDE-3 and STRIDE-6) for V116, its investigational 21-valent pneumococcal conjugate vaccine. The vaccine demonstrated positive immunogenicity and safety, aiming to protect adults from invasive pneumococcal disease....more
Merck.com News Release • April 25, 2024
MSD announced robust financial results for the first quarter of 2024, with worldwide sales of $15.8 billion, an increase of 9% from Q1 2023. The company also raised its full-year 2024 financial outlook....more
Merck.com News Release • March 16, 2024
MSD announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA as monotherapy for the adjuvant treatment of adults with non-small cell lung cancer (NSCLC) who are at high risk of recurrence following complete resection and platinum-based chemotherapy....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including MSD, are just a search away.